Buspirone Versus Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder: A Double-Blind and Randomized Trial

Author： Davari-Ashtiani Rozita  

Publisher： Springer Publishing Company

ISSN： 0009-398X

Source： Child Psychiatry and Human Development, Vol.41, Iss.6, 2010-12, pp. : 641-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

By Casas Miguel  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 268-281

Informa Healthcare

Access to resources Recommend Favorite

Do the beneficial effects of extended methylphenidate treatment in boys with attention-deficit hyperactivity disorder dissipate rapidly during placebo treatment?

By  

Nordic Journal of Psychiatry, Vol. 53, Iss. 1, 1999-03 ,pp. : 55-60

Informa Healthcare

Access to resources Recommend Favorite

Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate

By Sangal J.M.   Sangal R.B.  

Clinical Neurophysiology, Vol. 115, Iss. 1, 2004-01 ,pp. : 188-193

Elsevier

Access to resources Recommend Favorite

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

By Aron A.R.   Dowson J.H.   Sahakian B.J.   Robbins T.W.  

Biological Psychiatry, Vol. 54, Iss. 12, 2003-12 ,pp. : 1465-1468

Elsevier

Access to resources Recommend Favorite

Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis And Treatment

By Thomas J. Lawrence  

Archives of Clinical Neuropsychology, Vol. 23, Iss. 5, 2008-09 ,pp. : 623-625

Oxford University Press

Access to resources Recommend Favorite